Trine Tramm is consultant, M.D. at Department of Pathology, Aarhus University Hospital with special responsibility for breast pathology. She is a board-member of the Pathology Committee of the Danish Breast Cancer Group. Her research interests are identification of biomarkers with predictive value in relation to the benefit of radiotherapy, particularly in patients with breast cancer and head/neck cancer, including the importance of the pre-existing immune system for the effect of radiotherapy. Furthermore, she is principal investigator of a national study on precursor lesions in breast cancer.